Phase I human trial of parent molecule (TB-4) showed no serious adverse events Mild injection site reactions possible Same theoretical angiogenesis/tumor concern as BPC-157 Head rush or lightheadedness reported anecdotally at higher doses Can You Stack BPC-157 and TB-500
This list highlights commonly-cited boundaries from the published literature, not a personalized screen
It supports muscle recovery, nutrient utilization and daily performance as part of a broader wellness plan
Published work links its activity to nitric-oxide pathway signaling, FAK-paxillin cell-adhesion pathways, growth-factor receptor expression, and dopaminergic and serotonergic systems
Primary research applications include cognitive impairment models, HGF/c-Met signaling studies, and neurodegeneration research in rodent models
Product quality represents a significant safety variable